Long Focus Capital Management, LLC - Q2 2022 holdings

$954 Million is the total value of Long Focus Capital Management, LLC's 112 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 46.5% .

 Value Shares↓ Weighting
NewINTEL CORPcall$253,827,0006,785,000
+100.0%
26.60%
NewCOMCAST CORP NEWcall$89,260,0002,289,900
+100.0%
9.35%
NewCITIGROUP INCcall$56,108,0001,220,000
+100.0%
5.88%
NewANHEUSER BUSCH INBEV SA/NVcall$33,719,000625,000
+100.0%
3.53%
NewBRISTOL-MYERS SQUIBB COcall$23,100,000300,000
+100.0%
2.42%
INTC BuyINTEL CORP$21,885,000
+42.4%
585,000
+88.7%
2.29%
+16.2%
BuyOCWEN FINL CORP$18,826,000
+83.6%
687,095
+59.2%
1.97%
+49.7%
IOVA BuyIOVANCE BIOTHERAPEUTICS INC$17,940,000
+52.8%
1,625,000
+130.5%
1.88%
+24.7%
FB BuyMETA PLATFORMS INCcl a$17,270,000
-2.7%
107,100
+34.2%
1.81%
-20.6%
BuyAPOLLO GLOBAL MGMT INC$11,171,000
+124.0%
230,430
+186.5%
1.17%
+82.7%
LILAK BuyLIBERTY LATIN AMERICA LTD$10,407,000
+6.2%
1,336,000
+30.7%
1.09%
-13.3%
FTAI BuyFORTRESS TRANS INFRST INVS L$9,863,000
+6.4%
510,000
+41.7%
1.03%
-13.2%
LBTYK BuyLIBERTY GLOBAL PLC$9,499,000
-10.6%
430,000
+4.9%
1.00%
-27.1%
BuyGENERAL ELECTRIC CO$9,437,000
+51.4%
148,225
+117.6%
0.99%
+23.5%
CZR BuyCAESARS ENTERTAINMENT INC NE$9,384,000
+1112.4%
245,000
+2350.0%
0.98%
+892.9%
FLEX BuyFLEX LTDord$9,203,000
+30.6%
636,000
+67.4%
0.96%
+6.4%
ADAP BuyADAPTIMMUNE THERAPEUTICS PLCsponds adr$7,955,000
-12.8%
4,679,491
+5.6%
0.83%
-28.9%
CLLS BuyCELLECTIS S Aspon ads$7,900,000
-31.6%
2,791,610
+9.8%
0.83%
-44.2%
BTU BuyPEABODY ENGR CORP$7,785,000
+26.9%
365,000
+46.0%
0.82%
+3.6%
LC NewLENDINGCLUB CORP$7,216,000617,239
+100.0%
0.76%
CHK BuyCHESAPEAKE ENERGY CORP$6,894,000
+58.5%
85,000
+70.0%
0.72%
+29.2%
AL BuyAIR LEASE CORPcl a$6,853,000
+9.6%
205,000
+46.4%
0.72%
-10.6%
CTRN NewCITI TRENDS INC$6,268,000265,047
+100.0%
0.66%
QMCO BuyQUANTUM CORP$5,835,000
+29.4%
4,109,177
+106.9%
0.61%
+5.5%
AZUL BuyAZUL S Asponsr adr pfd$5,787,000
-20.7%
815,000
+68.0%
0.61%
-35.4%
BCS BuyBARCLAYS PLCadr$5,700,000
+44.3%
750,000
+50.0%
0.60%
+17.5%
SPOT NewSPOTIFY TECHNOLOGY S A$5,630,00060,000
+100.0%
0.59%
COOP BuyMR COOPER GROUP INC$5,511,000
+119.4%
150,000
+172.7%
0.58%
+78.9%
TLYS BuyTILLYS INCcl a$5,230,000
+210.4%
745,000
+313.9%
0.55%
+152.5%
INSM BuyINSMED INC$4,930,000
+31.1%
250,000
+56.2%
0.52%
+7.0%
CURO BuyCURO GROUP HOLDINGS CORP$4,749,000
-14.1%
858,784
+102.7%
0.50%
-29.9%
PYPL BuyPAYPAL HLDGS INC$4,693,000
-20.0%
67,200
+32.5%
0.49%
-34.7%
UBER BuyUBER TECHNOLOGIES INC$4,501,000
+40.2%
220,000
+144.4%
0.47%
+14.3%
BuyHYZON MOTORS INC$4,410,000
-46.9%
1,500,000
+15.4%
0.46%
-56.7%
WYNN BuyWYNN RESORTS LTD$4,274,000
+7.2%
75,000
+50.0%
0.45%
-12.5%
C BuyCITIGROUP INC$3,955,000
-2.5%
86,000
+13.2%
0.41%
-20.5%
GGAL BuyGRUPO FINANCIERO GALICIA S.Asponsored adr$3,870,000
-25.3%
560,000
+16.7%
0.41%
-39.0%
LBRDA NewLIBERTY BROADBAND CORP$3,168,00027,900
+100.0%
0.33%
CMCSA BuyCOMCAST CORP NEWcl a$3,139,000
+49.0%
80,000
+77.8%
0.33%
+21.4%
AKRO NewAKERO THERAPEUTICS INC$2,741,000290,000
+100.0%
0.29%
KSS NewKOHLS CORP$2,677,00075,000
+100.0%
0.28%
ASPU BuyASPEN GROUP INC$2,659,000
-25.4%
2,713,592
+23.4%
0.28%
-39.1%
NXTC BuyNEXTCURE INC$2,614,000
+53.7%
556,105
+58.9%
0.27%
+25.1%
CPRI NewCAPRI HOLDINGS LIMITED$2,526,00061,588
+100.0%
0.26%
BAC NewBK OF AMERICA CORP$2,490,00080,000
+100.0%
0.26%
OMF BuyONEMAIN HLDGS INC$2,430,000
+105.1%
65,000
+160.0%
0.26%
+67.8%
SGMO BuySANGAMO THERAPEUTICS INC$2,194,000
+11.1%
530,000
+55.9%
0.23%
-9.4%
HEAR NewTURTLE BEACH CORP$1,835,000150,000
+100.0%
0.19%
VINC BuyVINCERX PHARMA INC$1,294,000
-24.8%
980,000
+127.8%
0.14%
-38.5%
FOA BuyFINANCE OF AMERICA COMPAN$1,138,000
-42.4%
725,000
+11.5%
0.12%
-53.1%
NESR BuyNATIONAL ENERGY SERVICES REU$1,085,000
+84.5%
160,000
+128.6%
0.11%
+50.0%
LOMA BuyLOMA NEGRA C I A S A MTN 14sponsored ads$1,067,000
+9.8%
210,000
+23.5%
0.11%
-10.4%
TUEM BuyTUESDAY MORNING CORP$1,072,000
-57.6%
2,977,742
+29.5%
0.11%
-65.5%
RXDX NewPROMETHEUS BIOSCIENCES INC$988,00035,000
+100.0%
0.10%
BuyACHIEVE LIFE SCIENCES INC$867,000
+91.0%
177,596
+196.0%
0.09%
+56.9%
ANIX BuyANIXA BIOSCIENCES INC$507,000
+59.9%
165,701
+43.2%
0.05%
+29.3%
TIL NewINSTIL BIO INC$462,000100,000
+100.0%
0.05%
FCX NewFREEPORT-MCMORAN INCcl b$439,00015,000
+100.0%
0.05%
NewCARIBOU BIOSCIENCES INC$434,00080,000
+100.0%
0.04%
PLCE NewCHILDRENS PL INC NEW$429,00011,030
+100.0%
0.04%
BuyHYZON MOTORS INC*w exp 10/02/202$396,000
-53.7%
600,700
+20.1%
0.04%
-62.7%
BuyBELLICUM PHARMACEUTICALS INC$390,000
-24.7%
327,692
+36.7%
0.04%
-38.8%
DXLG NewDESTINATION XL GROUP INC$170,00050,000
+100.0%
0.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ANTERO RESOURCES CORP11Q2 20245.0%
ALIBABA GROUP HLDG LTD11Q2 20243.5%
ENERGY TRANSFER L P11Q2 20242.9%
ASSURED GUARANTY LTD11Q2 20242.4%
ONITY GROUP INC11Q2 20242.1%
IOVANCE BIOTHERAPEUTICS INC11Q2 20241.9%
LIBERTY LATIN AMERICA LTD11Q2 20241.3%
COMCAST CORP NEW11Q2 20241.6%
PEABODY ENGR CORP11Q2 20241.2%
AZUL S A11Q2 20240.9%

View Long Focus Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Long Focus Capital Management, LLC Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Oportun Financial CorpApril 17, 20241,740,7775.0%
Hyzon Motors Inc.March 01, 202419,617,2448.0%
Adaptimmune Therapeutics PLCFebruary 14, 202412,086,9155.3%
ASPEN GROUP, INC.February 14, 20242,713,59210.7%
Cellectis S.A.February 14, 20244,487,2936.3%
CURO Group Holdings Corp.February 14, 20243,396,1308.2%
OCWEN FINANCIAL CORPFebruary 14, 2024652,0888.5%
QUANTUM CORP /DE/February 14, 20249,160,8199.6%
TILLY'S, INC.February 14, 20241,831,9318.1%
Vincerx Pharma, Inc.February 14, 20241,098,7535.1%

View Long Focus Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
SC 13G2024-08-07
13F-HR2024-05-14
SC 13G2024-04-17
SC 13G/A2024-03-01
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Long Focus Capital Management, LLC's complete filings history.

Compare quarters

Export Long Focus Capital Management, LLC's holdings